Xenetic Biosciences, Inc. (XBIO)
Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 20261 patent granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Xenetic Biosciences, Inc.’s names, not what it holds today.
2 published
2 published
| Granted | Patent | Title | Field | Owner as printed |
|---|---|---|---|---|
| Jan 29, 2019 | 10,188,739 | Compositions and methods for administering insulin or insulin-like protein to the brain | Pharmaceuticals | XENETIC BIOSCIENCES, INC. |
| Published | Application | Title | Field | Owner as printed |
|---|---|---|---|---|
| May 29, 2025 | 2025/0170241 | CHIMERIC ANTIGEN RECEPTOR T-CELL TREATMENTS TARGETED TO CHROMATIN FRAGMENTS AND EXTRACELLULAR TRAPS | Medical technology | XENETIC BIOSCIENCES, INC. |
| Aug 15, 2024 | 2024/0269300 | METHODS OF USING GLYCOPOLYSIALYLATED THERAPEUTIC PROTEINS | Pharmaceuticals | XENETIC BIOSCIENCES, INC. |
| Apr 7, 2022 | 2022/0105190 | METHODS OF USING GLYCOPOLYSIALYLATED THERAPEUTIC PROTEINS | Pharmaceuticals | XENETIC BIOSCIENCES, INC. |
| Aug 27, 2015 | 2015/0238620 | Compositions and Methods for Administering Insulin or Insulin-Like Protein to the Brain | Pharmaceuticals | XENETIC BIOSCIENCES, INC. · patent 10,188,739 granted from it |
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.